Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
11/08/1995 | EP0680761A1 Topical medicament having cicatrizing activity |
11/08/1995 | EP0680749A2 Cosmetic composition comprising an antagonist of substance P |
11/08/1995 | EP0680745A2 Use of antifungals and or halogenated antibacterial agents for diminishing hair loss |
11/08/1995 | EP0680338A1 Ganglioside-klh conjugate vaccines with qs-21 |
11/08/1995 | EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
11/08/1995 | EP0680323A1 Synergising association having an antagonist effect on nk1 and nk2 receptors. |
11/08/1995 | EP0502143B1 Composition for treating ocular pain |
11/08/1995 | EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
11/08/1995 | CN1111125A Liposome solutions |
11/07/1995 | US5464854 Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S. |
11/07/1995 | CA2020590C Solid pharmaceutical composition containing a core and an outer layer |
11/02/1995 | WO1995029257A2 Apolipoprotein e polymorphism and treatment of alzheimer's disease |
11/02/1995 | WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties |
11/02/1995 | WO1995028948A1 Compositions comprising dna damaging agents and p53 |
11/02/1995 | WO1995028947A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
11/02/1995 | WO1995028945A1 Antiviral compositions for treating aids, and method for preparing same |
11/02/1995 | WO1995028943A1 USE OF SPIRAMYCIN FOR TREATING GASTROINTESTINAL DISORDERS CAUSED BY $i(H. PYLORI) |
11/02/1995 | WO1995028926A1 Pde iv inhibitors for treating multiple sclerosis |
11/02/1995 | WO1995028906A1 Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation |
11/02/1995 | EP0679630A1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses |
11/02/1995 | EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
11/02/1995 | EP0679090A1 Method for treating myofascial pain syndrome |
11/02/1995 | EP0679086A1 Potentiation of temozolomide in human tumour cells |
11/02/1995 | CA2188697A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori |
11/02/1995 | CA2188269A1 Pde iv inhibitors for treating multiple sclerosis |
11/02/1995 | CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
11/02/1995 | CA2165209A1 Container filled with infusion liquids, infusion preparation and high calorie infusion preparation comprising vitamins |
10/31/1995 | US5462968 EP2 -receptor agonists as agents for lowering intraocular pressure |
10/31/1995 | US5462950 Administering raloxifene or salt |
10/26/1995 | WO1995028474A1 Dna encoding bradykinin b1 receptor |
10/26/1995 | WO1995028174A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
10/26/1995 | WO1995028166A2 Method for implanting encapsulated cells in a host |
10/26/1995 | WO1995028157A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
10/26/1995 | WO1995028151A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
10/26/1995 | DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis |
10/26/1995 | DE4410997A1 Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen Pharmaceutical drugs for the prevention and treatment of endothelial dysfunction |
10/26/1995 | CA2187773A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
10/26/1995 | CA2187335A1 Method for implanting encapsulated cells in a host |
10/25/1995 | EP0678298A2 Use of 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid as immopotentiatory agent |
10/25/1995 | EP0678101A1 Growth differentiation factor-9 |
10/25/1995 | EP0678021A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
10/25/1995 | EP0678020A1 Compositions comprising cholesterol lowering agents and antioxidants |
10/25/1995 | EP0294392B1 Diagnostic and therapeutic antibody conjugates |
10/25/1995 | CN1110605A Method of treating fungal infections |
10/24/1995 | CA1337427C (quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes |
10/24/1995 | CA1337401C Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes |
10/23/1995 | CA2121952A1 Topical preparations for the treatment of acne and acneiform dermatitis |
10/19/1995 | WO1995027735A1 Apoptose inhibitor |
10/19/1995 | WO1995027511A1 NEW COMBINATION OF A β-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC |
10/19/1995 | WO1995027510A1 Screening methods for integumental inflammation modulating agents |
10/19/1995 | WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
10/19/1995 | WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia |
10/19/1995 | WO1995027487A1 Method of treating allergic rhinitis |
10/19/1995 | DE4413839C1 Prepn. to protect human bodies from oxidative processes |
10/19/1995 | CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
10/18/1995 | EP0677100A1 Method for production of neuroblasts |
10/18/1995 | EP0676958A1 Method for inhibiting intracellular viral replication |
10/17/1995 | US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin |
10/17/1995 | US5459133 Alpha-2 adrenergic agonists, treatment of age related loss of accommodation |
10/17/1995 | US5458885 Transdermal drug delivery device |
10/17/1995 | CA1337330C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
10/12/1995 | WO1995027202A1 Screening method using the rzr receptor family |
10/12/1995 | WO1995027045A1 The isolation and production of catalytic antibodies using phage technology |
10/12/1995 | WO1995026768A1 Methods for treating pulmonary vasoconstriction and asthma |
10/12/1995 | WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy |
10/12/1995 | WO1995026726A1 Pharmaceutical composition containing a class iii antiarrhythmic agent and a class iv antiarrhythmic agent |
10/12/1995 | WO1995026725A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
10/12/1995 | WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists |
10/12/1995 | DE4411956A1 Agents for influencing hyperactive immunological effector cells |
10/12/1995 | CA2187200A1 Nadh oxidase as a target in diagnosis and therapy |
10/12/1995 | CA2186783A1 Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions |
10/12/1995 | CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists |
10/12/1995 | CA2182700A1 Screening method using the rzr receptor family |
10/11/1995 | EP0676206A1 Antimalarial |
10/11/1995 | EP0676203A1 Pharmaceutical compositions of antiglucocorticoid compounds for treating or preventing symptoms of spontaneous or narcotic-induced withdrawal |
10/11/1995 | EP0675955A1 Molecular flashlight |
10/11/1995 | EP0675730A1 Therapeutic combination containing interferon |
10/11/1995 | EP0675719A1 Novel combination of benzoquinazoline antifolates and protecting agents |
10/11/1995 | EP0675714A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
10/11/1995 | EP0675689A1 Medical foods for the nutritional support of child/adult metabolic diseases |
10/11/1995 | EP0440704B1 Compositions for treating tobacco withdrawel symptoms |
10/11/1995 | CN1029935C Pharmaceutical preparation and process for same |
10/10/1995 | US5457133 Treating Parkinson's disease, memory disorders, Alzheimer's disease, depression and hyperactive syndrome |
10/09/1995 | CA2146600A1 Products with antiglucocorticoid activity used for preparing drugs intended for the prevention or the treatment of manifestations caused by a spontaneous or a precipitated withdrawal symptom due to narcotics or mixtures of narcotics; compositions containing the same |
10/05/1995 | WO1995026193A1 Use of hyaluronic acid and forms to prevent arterial restenosis |
10/05/1995 | WO1995026188A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
10/05/1995 | WO1995026134A1 Composition for inactivating irritants in fluids |
10/05/1995 | WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
10/05/1995 | CA2186606A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
10/04/1995 | EP0675103A2 Derivatives of essential fatty acids and nonsteroidal antiinflammatory drugs |
10/04/1995 | EP0674527A1 Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders |
10/04/1995 | EP0271577B1 Immunomodulating compositions and their use |
10/03/1995 | US5455265 For mammals; skin disorders, cancer, inflammatory disease, cardiovascular diorders, autoimmune diseases and others |
10/03/1995 | US5455240 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
10/03/1995 | US5455235 Drink containing lactosucrose and buffer; anticarcinogenic agents, enzyme inhibitors; shelf life |
09/28/1995 | WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis |
09/28/1995 | WO1995025537A1 Drug for relieving side effects caused by immunosuppressants |
09/28/1995 | WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY |
09/27/1995 | EP0673653A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
09/27/1995 | EP0673652A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |